SCHEMBL10412040

SCHEMBL10412040

O=C(Nc1ccc(CCc2ccccc2Cl)cc1)C1=C(O)c2ccccc2SC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.45
▸ POLB P06746 1/20 0.45
▸ PTGES O14684 1/20 0.43
▸ ALOX15 P16050 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ ADRB2 P07550 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ FFAR1 O14842 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.37
▸ KLKB1 P03952 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10411293 0.90 PTGES (0.42) MAPTPOLBPTGESALOX15TP53
SCHEMBL10412146 0.84 ALOX15 (0.44) MAPTPTGESALOX15TP53ALDH1A1
SCHEMBL10412488 0.84 MAPT (0.42) MAPTPTGESALOX15TP53SMN1; SMN2
SCHEMBL10411370 0.82 ALOX15 (0.45) MAPTPOLBPTGESALOX15TP53
SCHEMBL10413084 0.82 MAPT (0.39) MAPTPTGESALOX15TP53ALDH1A1
SCHEMBL10411301 0.82 NAMPT (0.43) MAPTTP53ALDH1A1KDM4ELMNA
SCHEMBL10412136 0.81 PTGES (0.43) MAPTPOLBPTGESTP53LMNA
SCHEMBL10411350 0.80 MAPT (0.39) MAPTPTGESALOX15TP53NPC1
SCHEMBL10412940 0.79 POLB (0.45) MAPTPOLBTP53ALDH1A1LMNA
SCHEMBL10412947 0.79 MAPT (0.50) MAPTPOLBPTGESTP53CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback